(AGI.L) AGI Therapeutics PLC Buy/Sell

News

(AFX UK Focus) 2009-09-22 07:23 BRIEF-AGI Therapeutics to focus on U.S. in business shake-up
Previous \| Next \| All news for this company
Article layout: raw
DUBLIN, Sept 22 (Reuters) - AGI Therapeutics Plc: TO IMPLEMENT A REVISED BUSINESS STRATEGY WHICH HAS BEEN ENDORSED BY THE `board.` WILL FOCUS ITS PRIMARY EFFORTS ON THE US MARKET WILL FOCUS ON THE DEVELOPMENT OF SPECIALTY PRODUCTS WHERE THERE IS AN UNMET `medical need.` WILL AIM TO BRING PRODUCTS TO THE MARKET EITHER DIRECTLY OR THROUGH `out-licensing to or partnering with established pharmaceutical companies` A DETAILED OPERATIONAL PLAN IS NOW BEING DEVELOPED AROUND CORE PRODUCTS, REZULAR AND AGI-004 H1 LOSS PER ORDINARY SHARE $0.14 CENTS (2008: $0.13 CENTS) (Dublin Newsroom; + 353 1 500 1529) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
Previous \| Next \| All news for this company
Article layout: raw